Nucyrna Therapeutics Inc.
Framingham, MA
- UEI
- VXG3XU1ASJD7
- CAGE
- 0QEE7
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1296 Worcester Rd #2303, Framingham, MA 01702, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Developing a SOD1-targeting irnaso oligonucleotide drug candidate with improved efficacy and safety compared to tofersen | Defense Health Agency | $660,000 |
Quick answers
What is Nucyrna Therapeutics Inc.'s UEI?
Nucyrna Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is VXG3XU1ASJD7.
What is Nucyrna Therapeutics Inc.'s CAGE code?
Nucyrna Therapeutics Inc.'s CAGE code is 0QEE7.
What is Nucyrna Therapeutics Inc.'s primary NAICS code?
Nucyrna Therapeutics Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Where is Nucyrna Therapeutics Inc. located?
Nucyrna Therapeutics Inc.'s physical address in SAM.gov is 1296 Worcester Rd #2303, Framingham, MA 01702, USA.
Is Nucyrna Therapeutics Inc. registered in SAM.gov?
Yes. Nucyrna Therapeutics Inc.'s SAM.gov registration is active through January 8, 2027.
What is Nucyrna Therapeutics Inc.'s most recent federal award?
Nucyrna Therapeutics Inc.'s most recent federal grant award is Developing a SOD1-targeting irnaso oligonucleotide drug candidate with improved efficacy and safety compared to tofersen (HT94252510504), from Defense Health Agency, on July 1, 2025.
On GovTribe
See Nucyrna Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors